Question 1

Is there a generic for Travoprost?

Accepted Answer

Yes. The FDA Orange Book lists 9 approved generic (ANDA) applications for Travoprost, referencing the brand IDOSE TR. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

Question 2

What is the reference-listed drug for Travoprost?

Accepted Answer

IDOSE TR (NDA 218010, GLAUKOS) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

Question 3

What patents protect Travoprost?

Accepted Answer

The Orange Book lists 11 patents against Travoprost products, with the earliest listed expiry in 2027. Listed patents cover the drug substance, drug product, or approved methods of use, and a generic launching before they expire must file a Paragraph IV certification.

Question 4

Does Travoprost have FDA marketing exclusivity?

Accepted Answer

Yes. The Orange Book records 1 marketing-exclusivity period for Travoprost. Exclusivity is granted by FDA at approval (for example new-chemical-entity, orphan-drug, or pediatric exclusivity) and runs independently of any listed patents.

Question 5

What dosage forms of Travoprost are approved?

Accepted Answer

Travoprost is approved in the following dosage forms: implant, solution/drops.

Product	Applicant	Application	TE	Approved
IDOSE TRRLD	GLAUKOS	NDA 218010	—	Dec 13, 2023
IZBARLD	NOVARTIS	NDA 204822	—	May 15, 2014
TRAVATAN ZRLD	SANDOZ	NDA 021994	AT2	Sep 21, 2006
TRAVATANRLD	ALCON PHARMS LTD	NDA 021257	—	Mar 16, 2001

Product	Applicant	Application	TE	Approved
TRAVOPROST	ALEMBIC	ANDA 214687	AT2	Dec 17, 2025
TRAVOPROST	SOMERSET THERAPS LLC	ANDA 217228	AT2	Sep 23, 2024
TRAVOPROST	GLAND	ANDA 218159	AT2	Jul 12, 2024
TRAVOPROST	LUPIN	ANDA 207040	—	May 03, 2024
TRAVOPROST	MICRO LABS	ANDA 203767	AT2	Mar 19, 2021
TRAVOPROST	ALEMBIC	ANDA 210458	—	Dec 20, 2019
TRAVOPROST	MYLAN	ANDA 205050	AT2	Jul 07, 2017
TRAVOPROST	APOTEX	ANDA 203431	AT2	Jul 10, 2015
TRAVOPROST	CHARTWELL RX	ANDA 091340	—	Mar 01, 2013

Patent	Expires	In	Type
8323630	Sep 20, 2027	in 1 yr 3 mo	Product
8388941	Sep 20, 2027	in 1 yr 3 mo	Product
9144561	Mar 13, 2029	in 2 yr 9 mo	Product
8754123	May 19, 2029	in 3 yr	Product
8722735	Oct 10, 2029	in 3 yr 4 mo	Product
8178582	Oct 10, 2029	in 3 yr 4 mo	Product
8268299	Oct 13, 2029	in 3 yr 4 mo	Product
12201557	Jun 18, 2030	in 4 yr 1 mo	SubstanceProductU-4129
11426306	Oct 17, 2030	in 4 yr 5 mo	Product
10206813	Oct 17, 2030	in 4 yr 5 mo	Product
12201555	Feb 14, 2031	in 4 yr 9 mo	SubstanceProduct

Travoprost

Brand (NDA) products · implant, solution/drops

Generic (ANDA) products (9)

Marketing exclusivity (1)

Listed patents (11)

Travoprost — frequently asked questions

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.